StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) stock

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.94−0.04 (-2.02%)

Close on Nov 17, 2026Market cap $155.54MP/E –Yield –

BridgeBio Oncology Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BridgeBio Oncology Therapeutics's market cap was $205.09M on Nov 11, 2026, against $974.91M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$205.09M-79.3%
2025Dec 31, 2025$991.54M–

More BridgeBio Oncology Therapeutics figures

See a number that looks wrong?